Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA-AF Japan): One-year safety and effectiveness analyses

J Arrhythm. 2020 Apr 15;36(3):406-407. doi: 10.1002/joa3.12340. eCollection 2020 Jun.
No abstract available

Publication types

  • Editorial